Jeff Brown’s 2021 Predictions: A “Second Crop” of CRISPR Profits Is Coming in 2021
Jeff is more bullish on CRISPR than ever. And he believes there’s a “second crop” of CRISPR profits that...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
Jeff is more bullish on CRISPR than ever. And he believes there’s a “second crop” of CRISPR profits that...
Today, we’re continuing our 2021 prediction series with Jeff. And we’ll be talking about a topic that longtime readers...
Let’s assume Joe Biden takes office on the 20th of January. What does that mean for the high-technology sector?
Read on for the lessons the world must learn from this pandemic, and see why Jeff believes his coverage...
In mid-December, I asked Jeff to sit down to revisit his predictions and to look forward to the new...
Protein folding is a very fascinating topic with big implications for biotechnology and medicine. And there’s one key discovery...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.